ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GEMoaB Announces Trial with Solid Tumor Candidate from UniCAR Cellular Immunotherapy Platform
December 24, 2020GEMoaB has apheresed the first patient in a Phase IA study with UniCAR-T-PSMA, the lead solid tumor product candidate from its proprietary UniCAR cellular immunotherapy platform. -
First-in-human universal CAR-T therapy trial begins
December 08, 2020The dose-finding trial will evaluate the safety and activity of UniCAR-T-PSMA in up to 16 patients with advanced relapsed/refractory, PSMA-positive solid tumours.
Pharma Sources Insight January 2025
